Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

Go back to Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

Roivant Sciences (ROIV) PT Raised to $26 at Citi

November 10, 2025 3:58 PM EST

Citi analyst Samantha Semenkow raised the price target on Roivant Sciences (NASDAQ: ROIV) to $26.00 (from $25.00) while maintaining a Buy rating.

Removes 90-Day Upside Catalyst Watch... More